Testing effectiveness (Phase 2)Study completedNCT00062075
What this trial is testing
Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
National Cancer Institute (NCI) 47